2023
DOI: 10.1111/adb.13267
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning with neuroimaging biomarkers: Application in the diagnosis and prediction of drug addiction

Abstract: Drug abuse is a serious problem worldwide. Owing to intermittent intake of certain substances and the early inconspicuous clinical symptoms, this brings huge challenges for timely diagnosing addiction status and preventing substance use disorders (SUDs). As a non-invasive technique, neuroimaging can capture neurobiological signatures of abnormality in multiple brain regions caused by drug consumption in each clinical stage, like parenchymal morphology alteration as well as aberrant functional activity and conn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 151 publications
(359 reference statements)
0
9
0
Order By: Relevance
“…Notably, our research is in part representative of progress in neuroscience and advances the application of machine-learning methods that use functional brain connections as feature values to build neuroimaging-based behavior prediction. The CPM is designed to uncover critical brain features that can be applied to improve the accuracy of diagnosis and the success of treatment for IAS in clinical practice ( Yang et al ., 2023 ). Within this framework, a growing number of studies have developed predictive models based on brain imaging features to distinguish those with IAD from healthy controls or to predict symptom severity.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, our research is in part representative of progress in neuroscience and advances the application of machine-learning methods that use functional brain connections as feature values to build neuroimaging-based behavior prediction. The CPM is designed to uncover critical brain features that can be applied to improve the accuracy of diagnosis and the success of treatment for IAS in clinical practice ( Yang et al ., 2023 ). Within this framework, a growing number of studies have developed predictive models based on brain imaging features to distinguish those with IAD from healthy controls or to predict symptom severity.…”
Section: Discussionmentioning
confidence: 99%
“…MMP could synergise with other paradigms, potentially involving neural mechanisms in plasticity recovery in the reward-punishment circuit, executive function and contextual memory, including the thalamus, hippocampus and frontal regions. 1 So far, the therapeutic effectiveness of MPP remains unclear, requiring further exploration through comparisons with other routine paradigms and placebo groups. Proposing an optimised approach (eg, MMP, rTMS, TAU, CBT, etc) is essential for maximising the use of medical resources.…”
Section: Discussionmentioning
confidence: 99%
“…Drug addiction is a chronic and recurrent encephalopathy characterised by impulsive behaviour, spiritual cravings, psychological distortion and physical damage. 1 According to the role of molecular biology mechanisms on the central nervous system, addictive substances can be classified as inhibitors (eg, opioids, etc), stimulants (eg, methamphetamine (MA), nicotine, cocaine, etc) and hallucinogens (eg, cannabis, etc). 1 As published by the World Drug Report 2022, over 284 million individuals aged 15–64 worldwide have reportedly abused drugs in the past 12 months, emphasising the international challenge of effective detox treatment.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, we aimed to investigat the link between the FC signature and treatment outcome, which was typically missed in previous phenotyping studies 20,27,28 . By examining the discriminative FC signature as a predictor of treatment response to rTMS in 45 CUD patients who were randomly assigned to receive either 5 Hz active or sham rTMS on the left dorsolateral prefrontal cortex, we demonstrated the utility of this diagnostic FC signature for prognostic purpose of predicting treatment response.…”
Section: Introductionmentioning
confidence: 99%